Cargando…
Bone-Targeting Nanoparticles of a Dendritic (Aspartic acid)(3)-Functionalized PEG-PLGA Biopolymer Encapsulating Simvastatin for the Treatment of Osteoporosis in Rat Models
Simvastatin (SIM) is a lipid-lowering drug that also promotes bone formation, but its high liver specificity may cause muscle damage, and the low solubility of lipophilic drugs limits the systemic administration of SIM, especially in osteoporosis (OP) studies. In this study, we utilized the bone-tar...
Autores principales: | Lin, Che-Wei, Lee, Chih-Yun, Lin, Sung-Yen, Kang, Lin, Fu, Yin-Chih, Chen, Chung-Hwan, Wang, Chih-Kuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503052/ https://www.ncbi.nlm.nih.gov/pubmed/36142447 http://dx.doi.org/10.3390/ijms231810530 |
Ejemplares similares
-
PEG–PLGA nanoparticles for encapsulating ciprofloxacin
por: Watcharadulyarat, Natsorn, et al.
Publicado: (2023) -
Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair
por: Tai, I-Chun, et al.
Publicado: (2013) -
Investigating a Curcumin-Loaded PLGA-PEG-PLGA Thermo-Sensitive Hydrogel for the Prevention of Alzheimer’s Disease
por: Lin, Yi-Wen, et al.
Publicado: (2022) -
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
por: Tang, Li, et al.
Publicado: (2012) -
Drug-loaded PEG-PLGA nanoparticles for cancer treatment
por: Zhang, Dan, et al.
Publicado: (2022)